Kawasaki disease in Australia, 1993-95.
OBJECTIVE
To describe the epidemiology, management, and rate of cardiac sequelae of Kawasaki disease in Australia.


METHODS
Cases were notified to the Australian Paediatric Surveillance Unit, an active national surveillance scheme, from May 1993 to June 1995.


RESULTS
139 cases of Kawasaki disease were confirmed. In 1994, the annual incidence was 3.7/100,000 children < 5 years old. Sixteen children were not admitted to hospital. Coronary artery abnormalities were reported in 35 (25%) children. Two patients were diagnosed at postmortem examination. Sixty six per cent of patients were diagnosed within 10 days of onset and 81% of these received intravenous gammaglobulin within 10 days. Forty five of the notified children did not fulfil the study criteria because of streptococcal infection or insufficient clinical criteria. One child with streptococcal infection had coronary artery dilatation.


CONCLUSIONS
Diagnosis of Kawasaki disease was delayed beyond 10 days in one third of patients, and almost 20% of children who could have received gammaglobulin within 10 days did not. The distinction between Kawasaki disease, streptococcal infection, and other possible diagnoses is problematic in some children.
Royle
J A
JA
Department of Immunology and Infectious Disease, Royal Alexandra Hospital for Children, Westmead, Australia.
Williams
K
K
Elliott
E
E
Sholler
G
G
Nolan
T
T
Allen
R
R
Isaacs
D
D
D000293:Adolescent; D017677:Age Distribution; D001315:Australia / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003327:Coronary Disease / Q000209:etiology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D013290:Streptococcal Infections / Q000175:diagnosis
D016756:Immunoglobulins, Intravenous